Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02375516 · ClinicalTrials.gov registry record · NA

Preventing Drug Abuse Among Hispanic Adolescents

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
678
Enrollment target

NCT02375516: Completed NA study, sponsored by Columbia University.

NCT02375516 is a NA study that has completed, run by Columbia University. The registered enrollment target is 678 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02375516, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
678 participants
Enrollment target

Study Summary

The planned research aims to delay the onset of drug use and reduce harmful use and abuse among Hispanic youths. The culturally-tailored prevention program will be delivered to youths by computer. Over 5 years, the program will be developed and tested in a randomized clinical trial. The intervention program will include 10 initial sessions, followed by annual booster sessions. Outcome measurements will involve baseline, post-intervention, and three annual follow-up data collections. The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among participants assigned to receive the intervention. If proven to be efficacious, the program will be revised and disseminated nationally.

Primary Outcome

Measures will ask participants to report, for the past 30 days, the number of: drinks of alcohol consumed, cigarettes smoked, puffs of marijuana, and times they consumed five or more drinks during one drinking occasion. Participants will also report past 30-day use of: inhalants, ecstasy, club drugs, prescription drugs for recreational use, heroin, diet pills, and hallucinogens.

Interventions

  • BEHAVIORAL Prevention Program

Trial Details

FieldValue
Enrollment Target 678 participants
Start Date 2012-09
Est. Completion 2021-04-07
Phase NA
Columbia University

958 total trials

What the finished NCT02375516 record still lists

NCT02375516 is an interventional study that assigns participants to a tested intervention. The registered 678 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).

The record links to 0 conditions, and to 1 intervention - of which Prevention Program is the first listed.

NCT02375516 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02375516 about?

NCT02375516 is a clinical study titled "Preventing Drug Abuse Among Hispanic Adolescents". The planned research aims to delay the onset of drug use and reduce harmful use and abuse among Hispanic youths. The culturally-tailored prevention program will be delivered to youths by computer. Over 5 years, the program will be developed and tested in a randomized clinical trial. The intervention...

What is the current status of trial NCT02375516?

This trial is currently completed. It is a NA study. The enrollment target is 678 participants. The study started on 2012-09. Estimated completion is 2021-04-07.

What interventions are being tested in trial NCT02375516?

The interventions under investigation include: Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02375516?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02375516's enrollment target sits among peer trials

678 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05372484 · 678 participants · NA

    Rice Technologies for Cervical Cancer Screening and Diagnosis

  • NCT06436924 · 678 participants

    Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day

  • NCT03501706 · 680 participants · NA

    An Assessment of Cognitive Improvement Training Among Mid-life Individuals

  • NCT05626452 · 680 participants · NA

    PrEP Optimization Among Women to Enhance Retention and Uptake

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02375516, the US trial registry maintained by the National Library of Medicine. NCT02375516 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.